Evidence map›Paper›PMID 32983978›Full record

ArticleFrontiers in oncology2020

CA IX Stabilizes Intracellular pH to Maintain Metabolic Reprogramming and Proliferation in Hypoxia.

Martin Benej, Eliska Svastova, Radivojka Banova, Juraj Kopacek, Adriana Gibadulinova, Martin Kery, Simona Arena, Andrea Scaloni, Monica Vitale, Nicola Zambrano and 3 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in oncology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
1.8field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 34 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Acid affairs in anti-tumour immunity.Cancer cell international · 2024
    Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 7 institutions in 3 countries.

Martin BenejThe Ohio State University Wexner Medical Center and OSU Comprehensive Cancer Center, Columbus, OH, United States.
Eliska SvastovaDepartment of Tumor Biology, Institute of Virology, Biomedical Research Center, Slovak Academy of Sciences, Bratislava, Slovakia.
Radivojka BanovaDepartment of Tumor Biology, Institute of Virology, Biomedical Research Center, Slovak Academy of Sciences, Bratislava, Slovakia.
Juraj KopacekDepartment of Tumor Biology, Institute of Virology, Biomedical Research Center, Slovak Academy of Sciences, Bratislava, Slovakia.
Adriana GibadulinovaDepartment of Tumor Biology, Institute of Virology, Biomedical Research Center, Slovak Academy of Sciences, Bratislava, Slovakia.
Martin KeryDepartment of Tumor Biology, Institute of Virology, Biomedical Research Center, Slovak Academy of Sciences, Bratislava, Slovakia.
Simona ArenaProteomics and Mass Spectrometry Laboratory, ISPAAM, National Research Council, Naples, Italy.
Andrea ScaloniProteomics and Mass Spectrometry Laboratory, ISPAAM, National Research Council, Naples, Italy.
Monica VitaleDipartimento di Medicina Molecolare e Biotecnologie Mediche, Università degli Studi di Napoli Federico II, Naples, Italy.
Nicola ZambranoDipartimento di Medicina Molecolare e Biotecnologie Mediche, Università degli Studi di Napoli Federico II, Naples, Italy.
Ioanna PapandreouThe Ohio State University Wexner Medical Center and OSU Comprehensive Cancer Center, Columbus, OH, United States.
Nicholas C DenkoThe Ohio State University Wexner Medical Center and OSU Comprehensive Cancer Center, Columbus, OH, United States.
Silvia PastorekovaDepartment of Tumor Biology, Institute of Virology, Biomedical Research Center, Slovak Academy of Sciences, Bratislava, Slovakia.
Biomedical Research Center of the Slovak Academy of Sciences · SKInstitute of Virology of the Slovak Academy of Sciences · SKThe Ohio State University Wexner Medical Center · USCeinge Biotecnologie Avanzate (Italy) · ITIstituto per il Sistema Produzione Animale in Ambiente Mediterraneo · ITNational Research Council · ITUniversity of Naples Federico II · IT

Funding

TUMOR HYPOXIA--MOLECULAR STUDIES &CLINICAL EXPLOITATIONP01CA067166 · NCI · STANFORD UNIVERSITY · PI LE, QUYNH-THU XUAN · 1996 to 2017
$25.5M
Overcoming hypoxic resistance to anti-cancer therapyR01CA255334 · NCI · OHIO STATE UNIVERSITY · PI DENKO, NICHOLAS C., LI, ZIHAI · 2021 to 2025
$2.9M
Decreasing oxygen metabolism to redcue hypoxia and radiosensitize tumors.R01CA163581 · NCI · OHIO STATE UNIVERSITY · PI DENKO, NICHOLAS C. · 2012 to 2016
$1.7M
NCI NIH HHS P01 CA067166NCI NIH HHS R01 CA163581NCI NIH HHS R01 CA255334
6 · The paper itself

Abstract

Tumor hypoxia represents a severe microenvironmental stress that is frequently associated with acidosis. Cancer cells respond to these stresses with changes in gene expression that promote survival at least in part through pH regulation and metabolic reprogramming. Hypoxia-induced carbonic anhydrase IX (CA IX) plays a critical adaptive role in response to hypoxic and acidic environments by catalytically hydrating extracellular CO

Indexed as

carbonic anhydrase IXglycolysishypoxiametabolismpH regulation

Identifiers

PMID32983978
PMCPMC7493625
OpenAlexW3082743306

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.